|
6/2022
vol. 109
abstract:
Special paper
Rosacea – diagnostic and therapeutic recommendations of the
Polish Dermatological Society. Part 2. Treatment
Magdalena Czarnecka-Operacz
8
,
Agnieszka Owczarczyk-Saczonek
14
,
Małgorzata Sokołowska-Wojdyło
13
,
Anna Zalewska-Janowska
17
,
- Department of Dermatology and Venereology, Medical University of Lodz, Lodz, Poland; Katedra i Klinika Dermatologii i Wenerologii, Uniwersytet Medyczny, Łódź, Polska
- Department of Dermatology, Medical University of Warsaw, Warsaw, Poland; Katedra i Klinika Dermatologiczna, Warszawski Uniwersytet Medyczny, Warszawa, Polska
- Department of Dermatology, Venereology and Paediatric Dermatology, Medical University of Lublin, Lublin, Poland; Katedra i Klinika Dermatologii, Wenerologii i Dermatologii Dziecięcej, Uniwersytet Medyczny, Lublin, Polska
- NZOZ Novaderm, Warsaw, Poland; NZOZ Novaderm, Warszawa, Polska
- Department of General and Oncological Dermatology, Regional Hospital, Opole, Poland; Oddział Dermatologii Ogólnej i Onkologicznej, Szpital Wojewódzki, Opole, Polska
- Jagiellonian University Medical College, Krakow, Poland; Katedra i Klinika Dermatologii i Wenerologii, Uniwersytet Jagielloński Collegium Medicum, Kraków, Polska
- Department of Dermatology, Paediatric and Oncologic Dermatology, Medical University of Lodz, Lodz, Poland; Klinika Dermatologii, Dermatologii Dziecięcej i Onkologicznej, Uniwersytet Medyczny, Łódź, Polska
- Department of Dermatology, Poznan University of Medical Sciences, Poznan, Poland; Katedra i Klinika Dermatologii, Uniwersytet Medyczny, Poznań, Polska
- Ludwik Rydygier Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Torun, Poland; Katedra Dermatologii i Wenerologii, Collegium Medicum im. Ludwika Rydygiera w Bydgoszczy, Uniwersytet Mikołaja Kopernika w Toruniu, Polska
- Department of Dermatology and Venereology, Medical University of Bialystok, Bialystok, Poland; Klinika Dermatologii i Wenerologii, Uniwersytet Medyczny, Białystok, Polska
- Department of Immunodermatology, Medical University of Warsaw, Warsaw, Poland; Zakład Immunodermatologii, Warszawski Uniwersytet Medyczny, Warszawa, Polska
- Department of Dermatology, Venereology and Allergology, Wroclaw Medical University, Wroclaw, Poland; Katedra i Klinika Dermatologii, Wenerologii i Alergologii, Uniwersytet Medyczny, Wrocław, Polska
- Department of Dermatology, Venereology and Allergology, Medical University of Gdansk, Gdansk, Poland; Katedra i Klinika Dermatologii, Wenerologii i Alergologii, Gdański Uniwersytet Medyczny, Gdańsk, Polska
- Department of Dermatology Sexually Transmitted Diseases and Clinical Immunology, University of Warmia and Mazury, Olsztyn, Poland; Katedra i Klinika Dermatologii, Chorób Przenoszonych Drogą Płciową i Immunologii, Uniwersytet Warmińsko-Mazurski, Olsztyn,
Polska
- Department of Dermatology, Military Medical Institute, Warsaw, Poland; Klinika Dermatologii, Wojskowy Instytut Medyczny, Warszawa, Polska
- Department of Dermatology, Institute of Medical Sciences, College of Medical Sciences, University of Rzeszow, Rzeszow, Poland; Zakład i Klinika Dermatologii, Instytut Nauk Medycznych, Kolegium Nauk Medycznych, Uniwersytet Rzeszowski, Rzeszów, Polska
- Psychodermatology Department, Pulmonology, Rheumatology and Clinical Immunology Chair, Medical University of Lodz, Lodz, Poland; Zakład Psychodermatologii, Katedra Pulmonologii, Reumatologii i Immunologii Klinicznej, Uniwersytet Medyczny, Łódź, Polska
- Department of Cosmetology and Aesthetic Dermatology, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Torun, Poland; Katedra Kosmetologii i Dermatologii Estetycznej, Collegium Medicum w Bydgoszczy, Uniwersytet Mikołaja Kopernika w Toruniu,
Polska
Dermatol Rev/Przegl Dermatol 2022, 109, 397-416
Online publish date: 2023/04/21
PlumX metrics:
Rosacea is a chronic inflammatory skin disease characterised by periods of remission and subsequent relapses typically provoked by environmental factors. Eruptions located on the face are easily visible and may be difficult to conceal, which leads to a decrease in patients’ self-esteem, quality of life, and general well-being. Since the aetiology of rosacea is multifactorial and not entirely understood, and the clinical characteristics and course of the disease are heterogeneous, therapy may be challenging. While a complete cure is not possible, in the majority of cases clinical improvement and long-term remission are satisfying both to the patient and physician. In recent years, the therapeutic approach has been significantly modified. Currently, the focus is placed on the need to personalise the treatment process and adapt it to the patients’ phenotypic characteristics. Combination therapies and new variants of existing topical and systemic drugs are increasingly being recommended. The mainstays of therapy are antiinflammatory agents. Proper skin care – along with the identification and avoidance of factors known to trigger consecutive episodes of rosacea – are also essential.
keywords:
rosacea, treatment
|
|
